Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Clinical trial NCT01468532 · COMPLETED

Trial details

NCT number: NCT01468532
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2011-10-01
Primary completion: 2017-07-20
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.